What is the prevalence and prognosis of AFE?
prevalence = 2/100,000
survival = approaching 80% (but significant neurological morbidity common place)
perinatal mortality 135/1000
(RCOG)
What is AFE?
An abnormal immune mediated response caused by a mothers exposure to fetal antigen in amniotic fluid, and occlusion of microvasculature in organs like the lungs by debris from amniotic fluid. It leads to respiratory distress, profound hypoxia, cardiovascular collapse and DIC.
How does AFE present?
Typically presents with collapse, profound hypoxia, respiratory distress, hypotension, and coagulopathy during labour or within 30 minutes of birth. It can progress to seizures and cardiac arrest; frequently have massive PPH due to atony and DIC.
What is the definitive management for AFE?
What is pathophysiology and progression/stages of AFE?
2 main aetiologies:
Progression:
What is the initial management of maternal collapse?
What are the possible obstetric causes of collapse?
How does LA toxicity present?
What is the treatment for LA toxicity?
What cardiac output is achieved in pregnant and non-pregnant adults?
Non-pregnant - 30% CO achieved
Pregnant (>20 weeks) - 10% CO achieved
What are the principals of perimortum caesarean?
Aims:
What is the management of magnesium sulphate toxicity?
What is the treatment for anaphylaxis?
What should be considered after clinical management of maternal collapse?